To view or add a comment, sign in Top 10 diabetes drugs by sales TOP 2: Jardiance (Empagliflozin) 2023 Sales: $10.73 Billion Company: Boehringer Ingelheim/Eli Lilly FDA First Approval: August 1, 2014 Indications: Type 2 diabetes, chronic heart failure, chronic kidney disease In 2023, Jardiance accounted for 28.8% of Boehringer Ingelheim's net sales, making it the top-performing product
What are the treatment goals of our Weight Doctors GLP-1 concept
Personally, we can say that brain fog, fatigue, vision disturbance, and other symptoms that we only have experienced when exposed to mold have been provoked by dosing with too much oral glutathione
Glutathione IV drip, a popular wellness treatment, stands out for its unique ability to deliver the antioxidant directly into the bloodstream, enhancing the absorption rate